Literature DB >> 28754232

Motor subtype changes in early Parkinson's disease.

Robert S Eisinger1, Christopher W Hess2, Daniel Martinez-Ramirez3, Leonardo Almeida4, Kelly D Foote5, Michael S Okun6, Aysegul Gunduz7.   

Abstract

INTRODUCTION: Distinct motor subtypes of Parkinson's disease (PD) have been described through both clinical observation and through data-driven approaches. However, the extent to which motor subtypes change during disease progression remains unknown. Our objective was to determine motor subtypes of PD using an unsupervised clustering methodology and evaluate subtype changes with disease duration.
METHODS: The Parkinson's Progression Markers Initiative database of 423 newly diagnosed PD patients was utilized to retrospectively identify unique motor subtypes through a data-driven, hierarchical correlational clustering approach. For each patient, we assigned a subtype to each motor assessment at each follow-up visit (time points) and by using published criteria. We examined changes in PD subtype with disease duration using both qualitative and quantitative methods.
RESULTS: Five distinct motor subtypes were identified based on the motor assessment items and these included: Tremor Dominant (TD), Axial Dominant, Appendicular Dominant, Rigidity Dominant, and Postural and Instability Gait Disorder Dominant. About half of the patients had consistent subtypes at all time points. Most patients met criteria for TD subtype soon after diagnosis. For patients with inconsistent subtypes, there was an overall trend to shift away from a TD phenotype with disease duration, as shown by chi-squared test, p < 0.001, and linear regression analysis, p < 0.05.
CONCLUSION: These results strongly suggest that classification of motor subtypes in PD can shift with increasing disease duration. Shifting subtypes is a factor that should be accounted for in clinical practice or in clinical trials.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Clustering; Parkinson's disease; Subtypes

Mesh:

Year:  2017        PMID: 28754232      PMCID: PMC5842811          DOI: 10.1016/j.parkreldis.2017.07.018

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  27 in total

Review 1.  The identification of Parkinson's disease subtypes using cluster analysis: a systematic review.

Authors:  Stephanie M van Rooden; Willem J Heiser; Joost N Kok; Dagmar Verbaan; Jacobus J van Hilten; Johan Marinus
Journal:  Mov Disord       Date:  2010-06-15       Impact factor: 10.338

Review 2.  What genetics tells us about the causes and mechanisms of Parkinson's disease.

Authors:  Olga Corti; Suzanne Lesage; Alexis Brice
Journal:  Physiol Rev       Date:  2011-10       Impact factor: 37.312

3.  A Personalized Approach to Parkinson's Disease Patients Based on Founder Mutation Analysis.

Authors:  Nir Giladi; Anat Mirelman; Avner Thaler; Avi Orr-Urtreger
Journal:  Front Neurol       Date:  2016-05-10       Impact factor: 4.003

4.  Differential effects of deep brain stimulation target on motor subtypes in Parkinson's disease.

Authors:  Maya Katz; Marta San Luciano; Kimberly Carlson; Ping Luo; William J Marks; Paul S Larson; Philip A Starr; Kenneth A Follett; Frances M Weaver; Matthew B Stern; Domenic J Reda; Jill L Ostrem
Journal:  Ann Neurol       Date:  2015-04       Impact factor: 10.422

Review 5.  Using cluster analysis for medical resource decision making.

Authors:  D Dilts; J Khamalah; A Plotkin
Journal:  Med Decis Making       Date:  1995 Oct-Dec       Impact factor: 2.583

Review 6.  The Parkinson Progression Marker Initiative (PPMI).

Authors: 
Journal:  Prog Neurobiol       Date:  2011-09-14       Impact factor: 10.885

7.  Benign tremulous parkinsonism.

Authors:  Keith A Josephs; Joseph Y Matsumoto; J Eric Ahlskog
Journal:  Arch Neurol       Date:  2006-03

8.  How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: comparison with the unified Parkinson's disease rating scale.

Authors:  Glenn T Stebbins; Christopher G Goetz; David J Burn; Joseph Jankovic; Tien K Khoo; Barbara C Tilley
Journal:  Mov Disord       Date:  2013-02-13       Impact factor: 10.338

9.  The association between motor subtypes and psychopathology in Parkinson's disease.

Authors:  J S A M Reijnders; U Ehrt; R Lousberg; D Aarsland; A F G Leentjens
Journal:  Parkinsonism Relat Disord       Date:  2008-10-31       Impact factor: 4.891

10.  Predictors of time to initiation of symptomatic therapy in early Parkinson's disease.

Authors:  Tanya Simuni; Jeffrey D Long; Chelsea Caspell-Garcia; Christopher S Coffey; Shirley Lasch; Caroline M Tanner; Danna Jennings; Karl D Kieburtz; Kenneth Marek
Journal:  Ann Clin Transl Neurol       Date:  2016-05-17       Impact factor: 4.511

View more
  12 in total

1.  Parkinson's disease motor subtype changes during 20 years of follow-up.

Authors:  Robert S Eisinger; Daniel Martinez-Ramirez; Adolfo Ramirez-Zamora; Christopher W Hess; Leonardo Almeida; Michael S Okun; Aysegul Gunduz
Journal:  Parkinsonism Relat Disord       Date:  2019-05-19       Impact factor: 4.891

Review 2.  Age Cutoff for Early-Onset Parkinson's Disease: Recommendations from the International Parkinson and Movement Disorder Society Task Force on Early Onset Parkinson's Disease.

Authors:  Raja Mehanna; Katarzyna Smilowska; Jori Fleisher; Bart Post; Taku Hatano; Maria Elisa Pimentel Piemonte; Kishore Raj Kumar; Victor McConvey; Baorong Zhang; Eng-King Tan; Rodolfo Savica
Journal:  Mov Disord Clin Pract       Date:  2022-09-10

Review 3.  Therapy of Parkinson's Disease Subtypes.

Authors:  Connie Marras; K Ray Chaudhuri; Nataliya Titova; Tiago A Mestre
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 7.620

4.  Patterns of striatal and cerebellar functional connectivity in early-stage drug-naïve patients with Parkinson's disease subtypes.

Authors:  Yanbing Hou; Ruwei Ou; Jing Yang; Wei Song; Qiyong Gong; Huifang Shang
Journal:  Neuroradiology       Date:  2018-09-22       Impact factor: 2.804

5.  Genome-Wide Association Study Meta-Analysis for Parkinson Disease Motor Subtypes.

Authors:  Isabel Alfradique-Dunham; Rami Al-Ouran; Rainer von Coelln; Cornelis Blauwendraat; Emily Hill; Lan Luo; Amanda Stillwell; Emily Young; Anita Kaw; Manuela Tan; Calwing Liao; Dena Hernandez; Lasse Pihlstrom; Donald Grosset; Lisa M Shulman; Zhandong Liu; Guy A Rouleau; Mike Nalls; Andrew B Singleton; Huw Morris; Joseph Jankovic; Joshua M Shulman
Journal:  Neurol Genet       Date:  2021-01-28

6.  Performance of longitudinal item response theory models in shortened or partial assessments.

Authors:  Leticia Arrington; Sebastian Ueckert; Malidi Ahamadi; Sreeraj Macha; Mats O Karlsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2020-07-02       Impact factor: 2.745

7.  Consistency and Stability of Motor Subtype Classifications in Patients With de novo Parkinson's Disease.

Authors:  Jingru Ren; Chenxi Pan; Yuqian Li; Lanting Li; Ping Hua; Ligang Xu; Li Zhang; Wenbin Zhang; Pingyi Xu; Weiguo Liu
Journal:  Front Neurosci       Date:  2021-03-01       Impact factor: 4.677

8.  Substantia nigra neuromelanin magnetic resonance imaging in patients with different subtypes of Parkinson disease.

Authors:  Lu Wang; Yayun Yan; Liyao Zhang; Yan Liu; Ruirui Luo; Ying Chang
Journal:  J Neural Transm (Vienna)       Date:  2021-02-09       Impact factor: 3.575

9.  Can We Predict the Motor Performance of Patients With Parkinson's Disease Based on Their Symptomatology?

Authors:  Karina Lebel; Christian Duval; Etienne Goubault; Sarah Bogard; Pierre J Blanchet
Journal:  Front Bioeng Biotechnol       Date:  2020-03-24

10.  Non-Motor Symptoms of the Postural Instability and Gait Difficulty Subtype in De Novo Parkinson's Disease Patients: A Cross-Sectional Study in a Single Center.

Authors:  Jingru Ren; Ping Hua; Chenxi Pan; Yuqian Li; Li Zhang; Wenbin Zhang; Pingyi Xu; Minming Zhang; Weiguo Liu
Journal:  Neuropsychiatr Dis Treat       Date:  2020-11-02       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.